End of Life and COVID-19; DCIS Doubles Cancer Risk; Training for 'Bad News'

<![CDATA[]]>(MedPage Today) — Cancer patients and survivors ponder end-of-life decisions in the era of COVID-19. (STAT)
Patients with pancreatic cancer associated with DNA repair defects lived 10 months longer when treated with platinum-based chemotherapy…

Source link

Related posts

American College of Gastroenterology releases monograph on IBS management


FMT restores microbial diversity post-antibiotics in patients with cirrhosis


Alterations in glucose metabolism in Vibrio cholerae serogroup O1 El Tor biotype strains


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy


COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World